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Background: The main objective of this study was to evaluate the efficacy of integrating the blood oxygen level
dependent functional magnetic resonance imaging (BOLD-fMRI) and diffusion tensor imaging (DTI) data into radiation
treatment planning for high-grade gliomas located near the primary motor cortexes (PMCs) and corticospinal tracts (CSTs).
Methods: A total of 20 patients with high-grade gliomas adjacent to PMCs and CSTs between 2012 and 2014 were
recruited. The bilateral PMCs and CSTs were located in the normal regions without any overlapping with target volume
of the lesions. BOLD-fMRI, DTI and conventional MRI were performed on patients (Karnofsky performance score≥ 70)
before radical radiotherapy treatment. Four different imaging studies were conducted in each patient: a planning
computed tomography (CT), an anatomical MRI, a DTI and a BOLD-fMRI. For each case, three treatment plans (3DCRT,
IMRT and IMRT_PMC&CST) were developed by 3 different physicists using the Pinnacle planning system.
Results: Our study has shown that there was no significant difference between the 3DCRT and IMRT plans in terms of
dose homogeneity, but IMRT displayed better planning target volume (PTV) dose conformity. In addition, we have
found that the Dmax and Dmean to the ipsilateral and contralateral PMC and CST regions were considerably decreased
in IMRT_PMC&CST group (p < 0.001).
Conclusions: In conclusion, integration of BOLD-fMRI and DTI into radiation treatment planning is feasible and
beneficial. With the assistance of the above-described techniques, the bilateral PMCs and CSTs adjacent to the target
volume could be clearly marked as OARs and spared during treatment.
Keywords: High-grade gliomas, Blood oxygen level dependent functional magnetic resonance imaging (BOLD-fMRI),
Diffusion tensor imaging (DTI), Three-dimensional conformal radiation treatment (3DCRT), Intensity-modulated radiation
therapy (IMRT), Radiation treatment planningBackground
Gliomas, which contain oligodendroglia, astrocytic and
ependymal lesions are the most common primary intracra-
nial tumors. High-grade gliomas, which make up 35 to 45%
of all newly diagnosed primary brain tumors worldwide,
have a very poor prognosis [1]. The three-dimensional* Correspondence: xdw80@yeah.net
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unless otherwise stated.conformal radiotherapy (3DCRT) has been considered as
the standard therapy for patients with high-grade gliomas
and intensity-modulated radiotherapy (IMRT) is becoming
increasingly used to improve dose conformity and spare
critical normal tissues. However, the risk of radiation-
induced brain injury increases with the increase of radi-
ation dose [2-4]. The strenuous endeavor has been made to
diminish radiation complications.
With the assistance of conventional magnetic resonance
imaging (MRI) and planning computed tomography (CT)
data, many critical intracranial structures, such as lens,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 T1-weighted MR imaging and the corresponding axial
CT after registration.
Wang et al. Radiation Oncology  (2015) 10:64 Page 2 of 7optic nerves and optic chiasm are well demarcated. How-
ever, it is difficult to accurately locate eloquent cortices
and fiber connections in the white matter of the brain by
routine neuroimaging. Excessive irradiation of eloquent
cortices and white matter fiber tracts is unavoidable. Blood
oxygen level dependent functional magnetic resonance
imaging (BOLD-fMRI) and diffusion tensor imaging (DTI)
have recently been used to identify the primary motor cor-
texes (PMCs) and corticospinal tracts (CSTs). These im-
aging techniques have been implemented in modern
neuronavigation systems and used to guide the surgical re-
moval of critically located intracranial lesions [5,6]. The
purpose of our study was to evaluate whether the incorp-
oration of BOLD-fMRI and DTI data into the 3D treat-
ment planning process could spare the healthy brain and
sensitive parts of the brain from high doses of radiation.
Methods
Ethical Approval was obtained from the General Hospital
of Ningxia Medical University Review Board and written
informed consent was obtained from patients. The study
was conducted with strict adherence to the Declaration of
Helsinki Principles.
Subjects
A total of 20 patients with high-grade gliomas adjacent
to PMCs and CSTs between May 2012 and February
2014 were recruited from the General Hospital of
Ningxia Medical University, China. Eleven male patients
and 9 female patients aged from 24 to 66 year-old were
enrolled in this study.
The glioma tissues in our study included 14 astrocyto-
mas (WHO Grade III) and 6 glioblastomas (WHO Grade
IV). The bilateral PMCs and CSTs were located in the nor-
mal regions without any overlapping with target volume
of the lesions. BOLD-fMRI, DTI and conventional MRI
were performed on patients (Karnofsky performance
score ≥ 70) before radical radiotherapy treatment.
Data acquisition and analysis
Four different imaging studies were conducted in each
patient: a planning CT for radiosurgery treatment and
target tracking during radiation therapy treatment deliv-
ering; an anatomical MRI to deliver a complete set of
morphological MR data; a DTI to provide white matter
tractography and a BOLD- fMRI to provide brain activa-
tion maps. Axial CT images (3-mm slice thickness) were
taken by a wide-bore Siemens Somatom Sensation Open
CT scanner (Siemens, Germany). MRI volumes were ac-
quired using a Signal HDx 3.0 T MRI scanner (General
Electric Company, USA).
BOLD fMRI data were obtained using fat-saturated
single-shot gradient echo planar imaging (EPI) (TE = 35 ms,
TR = 3,000 ms, acquisition matrix = 64 × 64 pixels, FOV=240 mm×240 mm2, flip angle = 90°, NEX= 1, 3 mm thick-
ness). A block design paradigm (5 cycles, 30 sec on and
30 sec off) was utilized. Functional areas relevant to each
treatment region were probed by Somatosensory tasks
(finger tapping with audio cue). Following the acquisition of
the functional data, gadolinium-enhanced high-resolution
images were acquired (TR/TE = 450/14, flip angle = 90°,
matrix = 256 × 256, FOV= 240 mm×240 mm2, and slice
thickness 3 mm skip 0 mm). After the images were taken,
data were transferred to the Matlab workstation for analysis.
The DTI data acquisition sequence was a spin echo-echo
planar imaging (SE-EPI) sequence with TR = 10,000 ms,
TE = 98.8 ms, acquisition matrix = 128 × 128 pixels; FOV=
240 mm×240 mm2; slice thickness = 3.0 mm. Diffusion-
weighted imaging with b factor of 1,000 mm2/s was taken
along 25 noncollinear directions. The acquisition time of
DTI sequence was 280 seconds. DTI data was analyzed on-
line by the advantage workstation of the MR scanner (AW
4.4). For CST analysis, a seed region of interest (ROI) and a
target ROI were placed on the posterior limb of the internal
capsule and pons (anterior blue portion on the color map).
Fiber tracking employed fractional anisotropy (FA) threshold
of 0.2 and a tract angular change of 30°. The color-coded FA
maps were merged with the anatomical MRI images. Re-
gions of interest were drawn on the fused FA maps.
The fused fMRI activation maps and the white matter
tracts overlaid on the anatomical MRI volume were
exported as separate grayscale dicom images and loaded
onto Pinnacle planning system software version 9.2 (Phi-
lips Medical Systems, Netherlands). The anatomical MRI
images were registered with the CT volume for each pa-
tient. Figure 1 shows the anatomical MRI images were
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glioma case.
Treatment planning
The target and organs at risk (OARs), i.e., optic nerves,
optic chiasm and brain stem were precisely described using
CT/anatomical MRI images. Both eyes were protected to
avoid beam damage during treatment planning. The PMCs
and the CSTs situated near the target were defined by a
radiologist and a neurosurgeon, using the tractography im-
ages and the fused activation maps. Gross tumor volumeFigure 2 Axial isodose distribution in a patient with high-grade gliom
IMRT_ PMC&CST, respectively. (orange) ipsilateral PMC (red square symbol)
symbol) contralateral CST.(GTV) was described as the operative cavity with any
remaining contrast-enhancing tissue on T1-weighted mag-
netic resonance imaging or as unresected enhancing tumor.
The initial clinical target volume (CTV1) was defined as the
T2 hyper intensity area (edema) with a 20 mm expansion.
An initial planning target volume (PTV1) was created by
adding a 30 mm expansion to the CTV1 to account for
setup uncertainties. A second clinical target volume (CTV2)
was defined as the contrast enhancement region in T1 with
an additional 25 mm margin. A PTV2 was generated by
adding a 30 mm expansion to the CTV2.a. The A, B and C show the dose distributions for 3DCRT, IMRT and
contralateral PMC (pink square symbol) ipsilateral CST (green square
Table 1 Comparison of target volume coverage between
3DCRT and IMRT
3DCRT IMRT t p
PTV1 (50 Gy)
Dmax (Gy) 65.06 ± 0.46 64.88 ± 0.66 1.461 0.160
Dmean (Gy) 59.78 ± 0.77 59.91 ± 0.85 −0.551 0.588
CI 1.219 ± 0.054 1.071 ± 0.025 10.492 <0.001*
HI 0.210 ± 0.008 0.213 ± 0.012 −1.177 0.254
PTV2 (60 Gy)
Dmax (Gy) 65.06 ± 0.46 64.88 ± 0.66 1.461 0.160
Dmean (Gy) 62.46 ± 0.39 62.36 ± 0.53 1.301 0.209
CI 1.178 ± 0.082 1.055 ± 0.049 5.552 <0.001*
HI 0.086 ± 0.022 0.082 ± 0.016 0.809 0.429
*Significant difference.
Table 2 Comparison of OAR sparing between 3DCRT and
IMRT
3DCRT (Gy) IMRT (Gy) t p
Ipsilateral lens Dmax 1.99 ± 1.00 2.67 ± 1.67 −1.938 0.068
Ipsilateral lens Dmean 1.52 ± 0.75 1.98 ± 1.45 −1.454 0.162
Contralateral lens Dmax 1.71 ± 0.74 2.38 ± 1.97 −1.885 0.075
Contralateral lens Dmean 1.34 ± 0.55 1.84 ± 1.69 −1.585 0.129
Ipsilateral optic nerve Dmax 12.54 ± 17.85 12.32 ± 13.38 0.156 0.877
Ipsilateral optic nerve Dmean 8.55 ± 11.99 8.57 ± 9.40 −0.014 0.989
Contralateral optic
nerve Dmax
7.55 ± 8.94 7.02 ± 7.68 1.025 0.318
Contralateral optic
nerve Dmean
5.14 ± 5.92 4.59 ± 4.76 1.364 0.188
Optic chiasm Dmax 12.53 ± 15.50 12.76 ± 13.53 −0.241 0.812
Optic chiasm Dmean 9.22 ± 11.64 8.28 ± 8.70 1.060 0.302
Brainstem Dmax 14.78 ± 14.77 14.04 ± 11.62 0.523 0.607
Brainstem Dmean 7.09 ± 8.31 6.52 ± 6.99 0.711 0.486
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3 different physicists using the Pinnacle planning system.
The first physicist created conventional 3DCRT plans
(3DCRT) and the PMCs and the CSTs situated near the
target were not taken in account by the physicist. The tar-
get and standard morphological OARs were considered in
this plan. The second physicist developed IMRT plans
(IMRT) and the PMCs and the CSTs situated near the tar-
get were not considered by the physicist. The third physi-
cist developed IMRT plans (IMRT_PMC&CST), and the
PMCs and the CSTs situated near the target were consid-
ered. Figure 2 shows the axial isodose distribution of a pa-
tient with high-grade glioma.
The treatment plans met the requirement that at least
95% of the PTV receives the prescribed dose. Cumula-
tive doses to the lenses, optic nerves, optic chiasm, and
brainstem were limited to a maximum dose of 54 Gy for
the last three structures and as low as practically achiev-
able for the former. For conventional 3DCRT treatment,
the prescribed dose was 50 Gy to the PTV1, immediately
followed by 10 Gy to the PTV2, with a total cumulative
dose of 50 Gy to the PTV1 and 60 Gy to the PTV 2 both
at 2 Gy per fraction. For IMRT plans, the prescribed
dose was 50 Gy to the PTV1 and 60 Gy to the PTV2,
which were delivered concurrently over 30 daily frac-
tions, with a fractional dose of 2 Gy to the PTV2.
Comparison criteria for the radiation treatment plans
The dose volume histograms (DVH) data were obtained
from each patient. The dose coverage was analyzed accord-
ing to the mean dose (Dmean), maximum dose (Dmax), con-
formity index (CI) and homogeneity index (HI). The CI was
defined as follows [7]: CI =VRI/PTV, where VRI represents
the volume covered by the prescription dose. A CI value of
1.0 indicates that the volume of the prescription isodose sur-
face is equal to that of the PTV. The HI was defined as fol-
lows [8]: HI = (D2−D98)/D50, where Dx% represents the
dose delivered to x% of the PTV. Lower HI values indicate a
more homogeneous target dose. OARs (e.g., brainstem, optic
chiasm, optic nerves, and lenses) and PMCs and CSTs were
compared based on the values of Dmax and Dmean.
Statistical analyses
The comparison of parameters between different plans was
analyzed by the paired two-tailed Student t test. Differences
were considered statistically significant at p < 0.05.
Results
Comparison of target volume coverage and OAR sparing
between 3DCRT and IMRT
Parameters related to dose coverage planning for
3DCRT and IMRT are presented in Tables 1 and 2. The
results indicated that there was no significant difference
between the 3DCRT and IMRT plans in terms of dosehomogeneity, but IMRT displayed better PTV dose con-
formity. Regarding the comparison of PTV1 Dmax,
PTV1 Dmean, PTV2 Dmax and PTV2 Dmean, there
was no significant difference between the 3DCRT and
IMRT plans. The dosimetric details of brainstem, optic
chiasm, optic nerves, and lenses revealed no significant
differences between the two plans and all of these organs
were strictly maintained within the dose limitations. The
Dmax and Dmean of PMCs and CSTs were observed in
both 3DCRT and IMRT plans (Table 3); however no sig-
nificant difference was found between the two plans.Comparison of target volume coverage and OAR sparing
between IMRT and IMRT_PMC&CST
Treatment plan parameters are shown in Tables 4 and 5.
According to the data presented, both PTV1 and PTV2





Ipsilateral lens Dmax 2.67 ± 1.67 2.76 ± 1.64 −1.574 0.132
Ipsilateral lens Dmean 1.98 ± 1.45 2.03 ± 1.50 −1.294 0.211
Contralateral lens Dmax 2.38 ± 1.97 2.43 ± 1.95 −1.063 0.126
Contralateral lens
Dmean
1.84 ± 1.69 1.89 ± 1.72 −0.940 0.359
Ipsilateral optic nerve
Dmax
12.32 ± 13.38 12.44 ± 13.91 −0.599 0.556
Ipsilateral optic nerve
Dmean
8.57 ± 9.40 8.78 ± 10.08 −1.126 0.274
Contralateral optic
nerve Dmax
7.02 ± 7.68 7.07 ± 7.71 −0.353 0.728
Contralateral optic
nerve Dmean
4.59 ± 4.76 4.66 ± 4.95 −0.729 0.475
Optic chiasm Dmax 12.76 ± 13.53 12.49 ± 13.20 1.488 0.153
Optic chiasm Dmean 8.28 ± 8.70 8.20 ± 8.63 0.573 0.573
Brainstem Dmax 14.04 ± 11.62 13.56 ± 11.08 1.260 0.223
Brainstem Dmean 6.52 ± 6.99 6.46 ± 7.05 0.790 0.439
Table 3 Comparion of radiation dose between 3DCRT and
IMRT
3DCRT (Gy) IMRT (Gy) t p
Ipsilateral PMC Dmax 46.50 ± 8.65 46.54 ± 7.77 −0.050 0.960
Ipsilateral PMC Dmean 28.45 ± 7.78 27.67 ± 8.06 1.429 0.169
Contralateral PMC Dmax 24.86 ± 9.89 21.40 ± 10.94 1.542 0.140
Contralateral PMC Dmean 14.73 ± 6.02 14.11 ± 7.57 0.390 0.701
Ipsilateral CST Dmax 51.26 ± 4.24 50.61 ± 4.72 1.801 0.088
Ipsilateral CST Dmean 36.51 ± 6.63 36.06 ± 7.57 0.893 0.383
Contralateral CST Dmax 35.64 ± 10.15 36.11 ± 10.05 −0.859 0.401
Contralateral CST Dmean 20.97 ± 7.43 18.90 ± 7.45 1.454 0.162
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significant differences between two groups. The Dmax
and Dmean to these conventional OARs (e.g., brainstem,
optic chiasm, optic nerves, and lenses) showed no signifi-
cant differences between the two plans. The Dmax to the
ipsilateral and contralateral PMC and CST regions was
considerably decreased by 28.7%, 24.5%, 20.2% and 37.6%,
respectively. The Dmean to the ipsilateral and contralat-
eral PMC and CST regions was considerably decreased by
27.8%, 30.4%, 23.1% and 33.4%, respectively (Table 6).Discussion
Radiation therapy is commonly applied to the brain tu-
mors due to its ability to control cell growth; however,
radiation therapy can have detrimental effects on the
central nervous system causing neurological complica-
tions. The response of cerebral tissue to radiation can
lead to the deficits in neural functions [9,10]. The extent
of neurologic deficit is associated with the location and
size of radiation-induced brain injury [11,12]. Efforts
dedicated to the precise division of brain lesions have
been made to reduce the risk of neurological complica-
tions caused by the radiation therapy.Table 4 Comparison of target coverage between IMRT
and IMRT_PMC&CST
IMRT IMRT_PMC&CST t p
PTV1 (50 Gy)
Dmax (Gy) 64.88 ± 0.66 65.04 ± 0.70 −0.806 0.430
Dmean(Gy) 59.91 ± 0.85 59.85 ± 0.68 0.633 0.534
CI 1.071 ± 0.025 1.073 ± 0.024 −1.077 0.295
HI 0.213 ± 0.012 0.209 ± 0.016 0.911 0.374
PTV2 (60 Gy)
Dmax (Gy) 64.88 ± 0.66 65.04 ± 0.70 −0.806 0.430
Dmean (Gy) 62.36 ± 0.53 62.41 ± 0.56 −0.287 0.777
CI 1.055 ± 0.049 1.039 ± 0.047 1.643 0.117
HI 0.082 ± 0.016 0.089 ± 0.016 −1.646 0.116The DTI and BOLD-fMRI have recently been used to
identify the white-matter pathways and functional struc-
tures of the brain. In our previous study, we proposed a
clinically feasible protocol of integrating BOLD-fMRI
and DTI to optimize the extent of resection involving
the cortical motor areas and subcortical white matter
tracts in patients with brain gliomas. Those information
helped neurosurgeons resected the maximum amount of
tumor while still preserving the most critical cortices of
the brain, thus resulting in enhanced postoperative quality
of life for patients [13]. The incorporation of this informa-
tion for radiosurgery planning has also been suggested.
Liu et al. has reported a novel method to integrate the
fMRI brain activation map with treatment planning for
stereotactic radiosurgery (SRS). Direct irradiation of the
eloquent cortices was avoided by multiple radiation arcs





Ipsilateral PMC Dmax 46.54 ± 7.77 33.20 ± 11.13 7.304 <0.001
Ipsilateral PMC Dmean 27.67 ± 8.06 19.99 ± 8.78 7.150 <0.001
Contralateral PMC Dmax 21.40 ± 10.94 16.16 ± 9.07 5.250 <0.001
Contralateral PMC Dmean 14.11 ± 7.57 9.82 ± 5.62 5.276 <0.001
Ipsilateral CST Dmax 50.61 ± 4.72 40.37 ± 6.55 9.233 <0.001
Ipsilateral CST Dmean 36.06 ± 7.57 27.72 ± 8.87 8.032 <0.001
Contralateral CST Dmax 36.11 ± 10.05 22.52 ± 10.36 6.959 <0.001
Contralateral CST Dmean 18.90 ± 7.45 12.59 ± 5.51 6.362 <0.001
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addition, it has been reported that the risk of radiation-
induced neuropathy was minimized by the integration of
tractography of the brain white matter with DTI into radi-
ation treatment planning of radiosurgery using Gamma
Knife [15]. Moreover, Pantelis et al. has demonstrated that
critical structures of brain could be marked and spared
with the aid of the integration of BOLD-fMRI and DTI
into CyberKnife stereotactic radiosurgery [16].
In this study, BOLD-fMRI and DTI were used to localize
the bilateral PMCs and CSTs and the information obtained
from these two technologies were integrated into radiation
treatment planning. The first part of our study (3DCRT
versus IMRT) indicated that there was no significant
reduction in the dose to bilateral PMCs and CSTs between
the 3DCRT and IMRT plans. The critical structures adja-
cent to the target volume marked as OARs can be better
spared during the IMRT planning process due to a steep
dose gradient and a high conformity [17,18]. The second
part of our study (IMRT versus IMRT_ PMC&CST), has
shown that a significant reduction in the dose to bilateral
PMCs and CSTs regions can be achieved without com-
promising the coverage of planning target volume and the
limiting dose to these conventional OARs.
Sparing of the bilateral PMCs and CSTs does not repre-
sent any significant breakthrough in the treatment of brain
tumors, but we have demonstrated that it is feasible to re-
duce the irradiation of critical structures adjacent to the
target volume. The development of the most appropriate
IMRT plan for the patient could be achieved by the identi-
fication of the important functional structures of the brain
tissues proximal to the tumors. Sparing these vital func-
tional structures is important to maintain quality of life,
even in those patients with restricted life expectancy. The
current study has shown that the DTI examination and
MR Spectroscopy are valuable tools to differentiate the
postoperative recurrent glioma from the radiation injury
for patients with a glioma [19,20].
We are currently investigating paradigms for Broca’s
and Wernicke’s areas (speech center), Broadmann-17
functional structures (visual center) and optic tracts.
The application of the fMRI in low grade cases has also
been validated.
Conclusions
In conclusion, integration of BOLD-fMRI and DTI into
radiation treatment planning is feasible and beneficial.
With the assistance of the above-described techniques, the
structures adjacent to suspicious cancerous lesions could
be clearly marked as OARs and spared during treatment.
However, a wider investigation and the longer-term
clinical follow up are required to further validate the
effect of the integration of BOLD-fMRI and DTI on spar-
ing normal tissues.Abbreviations
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